- Home
- OPP vs PMI Comparison
OPP vs PMI Comparison
Compare OPP & PMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Company Overview
Basic Information| Metric | OPP | PMI |
|---|---|---|
| Founded | 2010 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | |
| Sector | Finance | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 204.0M | 202.7M |
| IPO Year | N/A | 2025 |
Fundamental Metrics
Financial Performance| Metric | OPP | PMI |
|---|---|---|
| Price | $7.98 | $3.05 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 108.0K | ★ 2.3M |
| Earning Date | 01-01-0001 | 11-14-2025 |
| Dividend Yield | ★ 14.41% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $4,767,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 8.81 |
| 52 Week Low | $7.26 | $1.90 |
| 52 Week High | $8.83 | $13.68 |
Technical Indicators
Market Signals| Indicator | OPP | PMI |
|---|---|---|
| Relative Strength Index (RSI) | 41.23 | N/A |
| Support Level | $7.93 | N/A |
| Resistance Level | $8.09 | N/A |
| Average True Range (ATR) | 0.08 | 0.00 |
| MACD | 0.01 | 0.00 |
| Stochastic Oscillator | 32.50 | 0.00 |
Price Performance
Historical Comparison OPP
PMI
About OPP RiverNorth/DoubleLine Strategic Opportunity Fund Inc.
RiverNorth/DoubleLine Strategic Opportunity Fund Inc is a closed-end management investment company. The company's investment objective is to seek current income and overall total return.
About PMI Picard Medical Inc.
Picard Medical Inc operates through its wholly owned subsidiary, a medical technology company focused on developing, manufacturing, and commercializing an implantable Total Artificial Heart. It is engaged in designing, manufacturing, producing, supplying, marketing, and selling medical device products, including TAH. The TAH is an implantable system designed to assume the full function of a failed human heart in patients suffering from advanced heart failure.